seekingalpha.com
/2 weeks ago
Latest updates for Agnc
Fresh curated links around AGNC are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- AGNCO: This 8.75% Yielding Preferred Share Isn't The Highest, But My Favorite
- Analyst Report: AGNC Investment Corp
- AGNC Investment PFDs Reviewed: Rating Range From Buy To Strong Sell
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/2 weeks ago
AGNC Investment PFDs Reviewed: Rating Range From Buy To Strong Sell
suredividend.com
/1 week ago
Monthly Dividend Stock In Focus: AGNC Investment Corp.
Updated on May 20th, 2026 by Nathan Parsh AGNC Investment Corp (AGNC) has an extremely high dividend yield of above 14%. In terms of current dividend yield, AGNC is near the very t...
seekingalpha.com
/1 month ago
FGN And FGSN: F&G Annuities' 2 Long-Dated Notes - The Second Has A Buy Rating
realestatemagazine.ca
/3 weeks ago
eXp parent company acquires NextHome, begins trading as AGNT
eXp Realty's parent company has acquired U.S. franchise network NextHome and will now trade on the Nasdaq as AGNT. The latest in a rapid wave of consolidation. The post eXp parent...
fool.com
/2 weeks ago
AGNC Investment vs. Ares Capital: Which Ultra-High-Yield Financial Stock Is the Better Long-Term Buy?
AGNC Investment and Ares Capital have ultra-high yields and aggressive business models, but one has more growth appeal.
fool.com
/3 weeks ago
Genworth (GNW) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEWednesday, May 6, 2026 at 9 a.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Thomas J. McInerneyChief Financial Officer — Jerome...
seekingalpha.com
/1 month ago
AngioDynamics Non-GAAP EPS of -$0.07 beats by $0.04, revenue of $78.42M beats by $1.65M
cantechletter.com
/1 month ago
This analyst loves NervGen Pharma
In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$5.50 target on NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, An...
genengnews.com
/3 weeks ago
Novelty Nobility Expands AGC Biologics Deal to Take Product Candidate Through GMP Manufacturing
The project leverages AGC Biologics’ global network, having completed cell line development in Copenhagen, Denmark, to be followed by tech transfer to Chiba, Japan, for the next ma...
seekingalpha.com
/4 weeks ago
Goldcliff Resource Corporation (GCN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
bworldonline.com
/3 weeks ago
ACEN extends P3-B loan to subsidiary for Quezon wind farm
RENEWABLE ENERGY developer ACEN Corp. said it extended a short-term loan of up to P3 billion to its subsidiary Giga Ace 6, Inc. to fund the development of the 344.5-megawatt (MW) Q...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Agnc
seekingalpha.com
Recent coverage from public sources
Public source
feeds.feedburner.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
bworldonline.com
Recent coverage from public sources
Public source